Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/107753
Title: A budget impact analysis of Spiromax compared with Turbuhaler for the treatment of moderate to severe asthma: a potential improvement in the inhalation technique to strengthen medication adherence could represent savings for the Spanish Healthcare System and five Spanish regions
Author: Darbà, Josep
Ramírez, Gabriela
García-Rivero, Juan L.
Mayoralas, Sagrario
Pascual, José Francisco
Roger, Albert
Vargas, Diego
Bijedic, Adi
Keywords: Administració de medicaments
Asma
Malalties pulmonars obstructives cròniques
Tractament tèrmic
Economia de la salut
Administration of drugs
Asthma
Chronic obstructive pulmonary diseases
Heat treatment
Medical economics
Issue Date: Sep-2016
Publisher: Dove Medical Press
Abstract: To assess the economic impact of the introduction of DuoResp(®) Spiromax(®) by focusing on a potential improvement in the inhalation technique to strengthen medication adherence for the treatment of moderate to severe asthmatics in Spain and five Spanish regions including Andalusia, Catalonia, Galicia, Madrid, and Valencia. ...
Note: Reproducció del document publicat a: https://doi.org/10.2147/CEOR.S111453
It is part of: Clinicoeconomics and Outcomes Research, 2016, vol. 8 , p. 435-444
Related resource: https://doi.org/10.2147/CEOR.S111453
URI: http://hdl.handle.net/2445/107753
ISSN: 1178-6981
Appears in Collections:Articles publicats en revistes (Economia)

Files in This Item:
File Description SizeFormat 
668397.pdf270.56 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons